ATE429244T1 - Verwendung von faktor xiii zur stimulation der durchblutung von ischämischem gewebe - Google Patents
Verwendung von faktor xiii zur stimulation der durchblutung von ischämischem gewebeInfo
- Publication number
- ATE429244T1 ATE429244T1 AT05715335T AT05715335T ATE429244T1 AT E429244 T1 ATE429244 T1 AT E429244T1 AT 05715335 T AT05715335 T AT 05715335T AT 05715335 T AT05715335 T AT 05715335T AT E429244 T1 ATE429244 T1 AT E429244T1
- Authority
- AT
- Austria
- Prior art keywords
- factor xiii
- blood flow
- ischemic tissue
- stimulate blood
- stimulate
- Prior art date
Links
- 230000017531 blood circulation Effects 0.000 title 1
- 229940012444 factor xiii Drugs 0.000 title 1
- 230000000302 ischemic effect Effects 0.000 title 1
- 230000008081 blood perfusion Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 230000001052 transient effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04003950A EP1566183A1 (de) | 2004-02-20 | 2004-02-20 | Verwendung vom Faktor XIII zur Stimulierung der Durchblutung von ischämischem Gewebe |
| PCT/EP2005/001495 WO2005079839A1 (en) | 2004-02-20 | 2005-02-15 | Use of factor xiii for stimulating the perfusion of ischemic tissue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE429244T1 true ATE429244T1 (de) | 2009-05-15 |
Family
ID=34707356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05715335T ATE429244T1 (de) | 2004-02-20 | 2005-02-15 | Verwendung von faktor xiii zur stimulation der durchblutung von ischämischem gewebe |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20070167361A1 (de) |
| EP (2) | EP1566183A1 (de) |
| JP (1) | JP2007523111A (de) |
| KR (1) | KR20060123567A (de) |
| AT (1) | ATE429244T1 (de) |
| AU (1) | AU2005215114B2 (de) |
| CA (1) | CA2556805C (de) |
| DE (1) | DE602005014085D1 (de) |
| DK (1) | DK1718328T3 (de) |
| ES (1) | ES2325996T3 (de) |
| WO (1) | WO2005079839A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITTO20130532A1 (it) * | 2013-06-27 | 2014-12-28 | Donato Gemmati | Nuovo biomarcatore prognostico nell'infarto acuto del miocardio |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU674061B2 (en) * | 1993-03-30 | 1996-12-05 | Hoechst Japan Limited | Factor XIII for treatment of skin wounds |
| WO1998051333A1 (en) * | 1997-05-14 | 1998-11-19 | Zymogenetics, Inc. | Use of factor xiii for the manufacture of a medicament for the treatment of reperfusion injury and mucosal damage |
| WO2003065997A2 (en) * | 2002-02-06 | 2003-08-14 | Vicor Technologies, Inc. | Anti-infarction molecules |
-
2004
- 2004-02-20 EP EP04003950A patent/EP1566183A1/de not_active Withdrawn
-
2005
- 2005-02-15 AT AT05715335T patent/ATE429244T1/de active
- 2005-02-15 ES ES05715335T patent/ES2325996T3/es not_active Expired - Lifetime
- 2005-02-15 EP EP05715335A patent/EP1718328B1/de not_active Expired - Lifetime
- 2005-02-15 KR KR1020067016616A patent/KR20060123567A/ko not_active Ceased
- 2005-02-15 DE DE602005014085T patent/DE602005014085D1/de not_active Expired - Lifetime
- 2005-02-15 DK DK05715335T patent/DK1718328T3/da active
- 2005-02-15 CA CA2556805A patent/CA2556805C/en not_active Expired - Fee Related
- 2005-02-15 WO PCT/EP2005/001495 patent/WO2005079839A1/en not_active Ceased
- 2005-02-15 AU AU2005215114A patent/AU2005215114B2/en not_active Ceased
- 2005-02-15 JP JP2006553508A patent/JP2007523111A/ja active Pending
- 2005-02-15 US US10/589,957 patent/US20070167361A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2556805A1 (en) | 2005-09-01 |
| DE602005014085D1 (de) | 2009-06-04 |
| EP1566183A1 (de) | 2005-08-24 |
| JP2007523111A (ja) | 2007-08-16 |
| DK1718328T3 (da) | 2009-07-27 |
| KR20060123567A (ko) | 2006-12-01 |
| AU2005215114A1 (en) | 2005-09-01 |
| US20070167361A1 (en) | 2007-07-19 |
| EP1718328A1 (de) | 2006-11-08 |
| EP1718328B1 (de) | 2009-04-22 |
| AU2005215114B2 (en) | 2010-05-20 |
| ES2325996T3 (es) | 2009-09-28 |
| WO2005079839A1 (en) | 2005-09-01 |
| CA2556805C (en) | 2013-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006017071D1 (de) | Zusammensetzungen und verfahren zur behandlung von herzkrankheiten | |
| EP1758597A4 (de) | Verwendung von arzneimittelkombinationen zur behandlung der insulinresistenz | |
| DE602004017207D1 (de) | Verwendung von 1-aminocyclohexan-derivaten zur modifizierung der abscheidung von fibrillogenen as peptiden in amyloidpathien | |
| ATE525070T1 (de) | Silbininkomponente zur behandlung von hepatitis | |
| ATE432693T1 (de) | Kombinationstherapie zur behandlung von diabetes und dadurch bedingten leiden sowie zur behandlung von mittels erhöhung des glp-1-spiegels im blut verbesserten leiden | |
| EP1948799A4 (de) | Verwendung von bakteriocinen zur förderung von pflanzenwachstum und krankheitsresistenz | |
| EA200970446A1 (ru) | Связывающиеся с альбумином молекулы и их применение | |
| DK2195013T3 (da) | Terapeutisk anvendelse af en vækstfaktor, METRNL | |
| EP1755661A4 (de) | Verwendung von gelsolin zur behandlung von infektionen | |
| ATE530575T1 (de) | Demannosylierter rekombinanter faktor viii zur behandlung von patienten mit hämophilie a | |
| DE60328517D1 (de) | Neue verwendung von lycopin zur behandlung von erkrankungen im zusammenhang mit androgenwirkung | |
| CR10166A (es) | Uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento del trastorno bipolar y mania | |
| ATE499105T1 (de) | Behandlung oder vorbeugung von haut- oder gewebezuständen bei tieren unter verwendung von boryloxypyridylmethanonen | |
| ATE447551T1 (de) | Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen | |
| DE112008001135A5 (de) | Antiinflammatorische Wirkstoffkombinationen zur Behandlung von Erkrankungen der Haut und Schleimhäute | |
| ATE477798T1 (de) | Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung | |
| ATE438623T1 (de) | Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes | |
| DE602006010442D1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen | |
| ATE464895T1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen | |
| ATE510536T1 (de) | Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen | |
| ATE473735T1 (de) | Beta-2 adrenoceptor agonisten zur behandlung von bindegewebserkrankungen der haut | |
| ATE542536T1 (de) | 3-ä4-(dibenzoäb,füä1,4üoxazepin-11-yl)-piperazi - 1-ylü-2,2-dimethyl propansäure zur verwendung in der behandlung von schlafstörungen | |
| ATE472324T1 (de) | Isosorbid-mononitrat-derivate zur behandlung von okularer hypertonie | |
| DE502006007982D1 (de) | Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
| ATE472329T1 (de) | Verwendung der kombination von ciclesonid und antihistaminika zur behandlung von allergischer rhinitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1718328 Country of ref document: EP |